A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Children's Oncology Group
Milton S. Hershey Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Milton S. Hershey Medical Center
Milton S. Hershey Medical Center
Celgene
Istari Oncology, Inc.
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
University of Iowa
Children's Oncology Group
University of Colorado, Denver
Wake Forest University Health Sciences
University of Iowa
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
University of Iowa
Memorial Sloan Kettering Cancer Center
Stanford University
Wake Forest University Health Sciences
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Pfizer
Eli Lilly and Company